Forbes: Demanding Supply In College Admission: White Paper Calls For Expansion, Innovation At Selective Schools
What do college admissions and pharmaceutical companies have in common?
If a pharmaceutical company could “produce exponentially more vaccine doses but chose not to, there would be an uprising. And, if that pharmaceutical company disproportionately made the vaccine available to rich, white citizens, people would cry foul. A version of this happens every year in college admission, and unconscionably a culture of exclusivity celebrates this phenomenon rather than questions the inherent absurdity, inequity, and impact on qualified applicants." writes Brennan Barnard in Forbes.
